In our daily anaesthetic practice, we are confronted with an increasing number of patients
treated with either antiplatelet or anticoagulant agents. During the last decade, changes …

Background The reversibility of new/novel oral anticoagulants (NOAC) is not well
understood, whereas the reversal strategies for bleeding associated with vitamin k …

Immune‐mediated hemolytic anemia (IMHA) causes severe anemia in dogs and is
associated with considerable morbidity and mortality. Treatment with various …

Purpose To determine the risk of mechanical vessel wall damage resulting in hemorrhage
during and after hepatic and renal histotripsy in an anticoagulated in vivo porcine model …

Background Little to no data exist to guide treatment decision in patients with venous
thromboembolism (VTE) and chronic liver disease. Objectives To assess the effectiveness …

Background There is ongoing debate on what is optimal prophylactic agent to reduce
venous thromboembolism (VTE) following total joint arthroplasty (TJA). Although many …

Vitamin K antagonists (VKA) are the most widely used anticoagulants in the world. An
appropriate management of treated patients is crucial for their efficacy and safety. The …

Direct oral anticoagulants (DOACs) that inhibit the coagulation proteases thrombin or factor
Xa have replaced warfarin and other vitamin K antagonists (VKA) for most indications …

Contrast induced nephropathy (CIN) is traditionally associated with outpatient imaging
studies. More recently, patients afflicted with vascular pathologies are increasingly …

Objective The proportion and characteristics of Italian patients affected by venous
thromboembolism (VTE) treated with direct oral anticoagulants (DOACs) or vitamin K …